Latest rhabdomyosarcoma Stories
RnRMarketResearch.com adds “Rhabdomyosarcoma – Pipeline Review, H1 2015” to its store.
LONDON, April 2, 2015 /PRNewswire/ -- SummaryGlobalData's clinical trial report, "Non-Rhabdomyosarcoma Global Clinical Trials Review, H1, 2015" provides data on the Non-Rhabdomyosarcoma
ReportsnReports.com adds “Rhabdomyosarcoma - Pipeline Review, H2 2014” to its store.
St. Jude seeks public's continued support in helping to increase childhood cancer survival rates MEMPHIS, Tenn., Sept.
When two perfectly harmless genes, PAX3 and MAML3, abnormally combine during recurring chromosomal mismatch, they can turn dangerous.
Combined Gene and Protein Analysis of Sarcoma Confirms the Unique Clinical Utility of Caris Molecular Intelligence(TM) CHICAGO, June 2, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading
Gene Fusion Thought Unique to Cancer Occurs Naturally in Cells, UVA Finds Charlottesville, VA (PRWEB) January 23, 2014 A test used to detect a type of
Drugs that enhance a process called oxidative stress were found to kill rhabdomyosarcoma tumor cells growing in the laboratory and possibly bolstered the effectiveness of chemotherapy against this aggressive tumor of muscle and other soft tissue.